Xcell Therapeutics Inc. (KOSDAQ:373110)
South Korea · Delayed Price · Currency is KRW 3,275.00
+40.00 (1.24%)
Sep 19, 2025, 3:30 PM KST
Xcell Therapeutics Market Cap
Xcell Therapeutics has a market cap or net worth of 35.82 billion as of September 19, 2025. Its market cap has decreased by -31.00% in one year.
Market Cap
35.82B
Enterprise Value
37.82B
Revenue
1.49B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,275.00
Market Cap Chart
Since July 15, 2024, Xcell Therapeutics's market cap has decreased from 90.22B to 35.82B, a decrease of -60.29%. That is a compound annual growth rate of -54.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2025 | 35.82B | -19.29% |
| Dec 30, 2024 | 44.38B | -50.80% |
| Jul 15, 2024 | 90.22B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.88T |
| Celltrion | 37.63T |
| ALTEOGEN | 25.25T |
| SK Biopharmaceuticals | 8,888.55B |
| Yuhan | 8,872.07B |
| Peptron | 6,750.37B |
| PharmaResearch | 6,202.62B |
| ABL Bio | 5,910.48B |